Overweight Clinical Trial
Official title:
The Impact of Integrating an Internet Weight Control Program Into Primary Care
The investigators will conduct a randomized controlled trial comparing the effects of three interventions on weight loss at 12 months. The investigators propose to test the impact of integrating an effective automated Internet weight control program into primary care by recruiting patients and randomizing them to one of three conditions: A) Brief physician counseling plus usual care, B) Brief physician counseling plus referral and access to the Internet weight control program and, C) Brief physician counseling plus referral and access to the Internet weight control program plus brief follow-up email notes of support and accountability from Primary Care Physicians. The investigators hypothesize that an online program for weight control can be more effective by enhancing online follow-up with PCPs.
Status | Completed |
Enrollment | 611 |
Est. completion date | November 2016 |
Est. primary completion date | November 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 21 Years to 70 Years |
Eligibility |
INCLUSION CRITERIA: Physicians and Mid-level providers (Focus group and RCT): - Has medical license to practice primary care - Practice within 60 miles (focus group)/100 miles (RCT) of Penn State Hershey Medical Center - Practice not located at Penn State Hershey Medical Center campus (focus group) - Be active primary care providers (provide primary care at least 2 half days per week at one practice) - Not have had completed a weight management fellowship - Use internet in their office Patients (Focus group only): - Ages 21-60 - Body Mass Index between 25.0-50.0 kg/m2 - Have internet access at home or work - Patient of a primary care provider who practices Internal Medicine or Family Community Medicine - Has seen primary care provider in the last year, not including acute care Patients (RCT only) - Ages 21-70 - Body Mass Index between 25.0-50.0 kg/m2 - Have internet access at home or work - Patient of a PCP who is participating in the study - Patient has been seeing the PCP for at least 12 months and has no other PCP - The PCP must approve the patients' participation EXCLUSION CRITERIA: Physicians and Mid-level providers (RCT only) - Practice serves a specialty care population - Pregnant or planning to become pregnant in the next 3 months - Planning on changing practice locations in the next 12 months - Planning on retiring in the next 12 months Patients (Focus group and RCT) - Losing >5% of current body weight in the previous 6 months - Participating in a research project involving weight loss or physical activity in the previous 6 months - Pregnancy during the previous 6 months, lactating, or planning to become pregnant in the next 3 months (focus group)/12 months (RCT) - Planning on moving out of the area in the next 3 months (focus group)/12 months (RCT) - Current treatment for a condition or with a medication that could impact weight (Orlistat - aka. Alli, Phentermine, Topiramate - aka. Topamax) and are not willing to stop for duration of the study - Hospitalization for psychiatric problems during the prior year Patients (RCT only) - Had weight loss surgery - Planning on changing primary care provider in the next 12 months - Participating in an online or community weight loss program (e.g., Weight Watchers) and not willing to stop for the duration of the study - Doctor has diagnosed a heart condition and said should only do physical activity recommended by doctor - Feel pain in chest when doing physical activity - In the past month, have had chest pain when not doing physical activity - In the end stages of renal, liver or kidney diseases - Has heart failure - Has/had cancer in past 5 years (except non-melanoma skin cancer) - Cannot walk for exercise for 10 minutes - Not willing to participate in 12-month intervention - Taking insulin - Treated for or diagnosed with an eating disorder - Diagnosed with HIV - Two weeks of steroid use in past year |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Penn State Hershey Medical Center | Hershey | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Milton S. Hershey Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The University of Texas Health Science Center, Houston, University of North Carolina, Chapel Hill |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body Weight | Body weight and height will be measured by a research assistant using a portable, calibrated stadiometer (Tanita, Inc). Waist circumference will be measured using standard procedures, recorded to the nearest millimeter. | 12 months | No |
Secondary | Block Food Frequency Questionnaire | This questionnaire asks participants to estimate how often they consume a variety of specific foods. | 12 months | No |
Secondary | Paffenbarger Activity Questionnaire | This instrument has been used to estimate leisure time activity in many studies of weight loss (78, 112-113) and changes in energy expenditure using this measure correlate with changes in body weight over at least an 18 month period (114). A scoring algorithm allows the calculation of caloric expenditure overall as well as in activities of light, medium and high intensity. | 12 months | No |
Secondary | Patterns of medical care | After 12 months, data will be collected from medical charts using a standardized form to identify: 1) number of PCP visits, 2) use of any approved (e.g., Xenical) or off-label (e.g., Topiramate) weight loss medications after randomization, and 3) evaluations by a surgical weight control program. | 6 months | No |
Secondary | Use of the 5 A's during PCP Visits | After the index PCP visit and quarterly, subjects will complete a survey detailing the use the 5 A's (Ask, Advise, Assess, Assist and Arrange) during visits. Within 24-72 hours after the index visit, subjects will be called to complete the exit interview. | 12 months | No |
Secondary | Sociodemographics and tobacco use | Age, gender, race and ethnicity, smoking status, education and other demographics, will be measured based on standard self-report. | 12 months | No |
Secondary | Weight History Questionnaire | To measure past weight, past weight loss attempts and methods used to lose weight in the past, we will use the Weight History Questionnaire (WHQ) from the National Health and Nutrition Examination Survey (NHANES). | 12 months | No |
Secondary | Health Literacy | To measure health literacy, the Newest Vital Sign (NVS), a nutrition label that is accompanied by 6 questions that requires 3 minutes for administration will be used. | 12 months | No |
Secondary | Three-Factor Eating Questionnaire (TFEQ) | The TFEQ measures three dimensions of dietary restraint: cognitive restraint, disinhibition, perceived hunger. | 12 months | No |
Secondary | Depressive Symptoms | Depressive symptoms have been associated with body weight changes, so these symptoms will be measured with the 20-item Centers for Epidemiological Studies Depression Scale (CES-D). *If a patient scores a 25 or higher on the scale, research staff will notify their primary care physician; however, this does not make them ineligible for the study. | 12 months | No |
Secondary | Treatment Self-Regulation Scale (TSRQ) | The TSRQ will be used to measure autonomous (5 items) versus controlled (8 items) motivations, as well as total motivation (autonomous + controlled). | 12 months | No |
Secondary | Weight Control Self-Efficacy | Perceived competence in weight control will be measured using the Efficacy Life-Style Questionnaire (WEL). The WEL is a 20-item instrument consisting of five situational factors (Negative Emotions, Availability, Social Pressure, Physical Discomfort, and Positive Activities). | 12 months | No |
Secondary | Patient Satisfaction and Accountability | Patient satisfaction will be measured with the Patient Satisfaction Questionnaire 18 (PSQ18), which includes scales to measure technical quality, interpersonal manner, communication and time spent with the doctor with scale reliability between 0.79 and 0.93. Accountability will be measured with a 6-item measure developed by Mohr and colleagues (consultant), which measures the extent to which subjects believe that they are being monitored and the extent to which they are concerned about being judged by the monitor. | 12 months | No |
Secondary | Sedentary Behavior | This validated questionnaire asks participants about the duration of specific sedentary behaviors during a typical weekday and weekend day. | 12 months | No |
Secondary | Physical Activity Self Efficacy | This questionnaire asks about participants about their level of confidence in doing physical activity in certain situations. | 12 months | No |
Secondary | Eating Behavior Inventory | The Eating Behavior Inventory (EBI) is a validated questionnaire used by obesity researchers to measure the adoption of specific behaviors linked with weight-loss success. | 12 months | No |
Secondary | Internet Usage | This questionnaire asks participants about the frequency of their Internet use and the ways in which they use the Internet | 12 months | No |
Secondary | Analysis of text edits in PCP emails | We will analyze 100% of the personal notes added by PCPs to messages sent to patients in Condition C. Using a grounded theory approach, Dr. Hwang will analyze the content in the notes from PCPs and create a codebook and categories for these notes. | 12 months | No |
Secondary | Blood pressure | Blood pressure will be measured by a research assistant using an automatic blood pressure monitor (Omron) and standard procedures. | 12 months | No |
Secondary | Adherence (logins to website) | We will examine login data (overall and percentage of weeks logging in) as a mean and median, as well as a monthly percentage. | 12 months | No |
Secondary | Medication | Participants will be asked to bring their current prescription medications. The research coordinator will record the name and dose of each. | 12 Months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT02829229 -
Community-based Obesity Treatment in African American Women After Childbirth
|
N/A | |
Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A |